| scholarly article | Q13442814 |
| P50 | author | Pauline M. Maki | Q37386805 |
| Lauren L Drogos | Q55875821 | ||
| P2093 | author name string | Leah H Rubin | |
| Stacie E Geller | |||
| Lee P Shulman | |||
| Suzanne Banuvar | |||
| Deanne Fornelli | |||
| P2860 | cites work | Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial | Q24650609 |
| Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones | Q28275541 | ||
| Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta | Q28283637 | ||
| Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate | Q28578932 | ||
| Development and validation of brief measures of positive and negative affect: The PANAS scales | Q29614730 | ||
| Cognitive Abilities: Use of Family Data as a Control to Assess Sex and Age Differences in Two Ethnic Groups | Q30706572 | ||
| Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials | Q30870451 | ||
| The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones | Q34162974 | ||
| Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. | Q34227271 | ||
| Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms | Q34402334 | ||
| Neurobehavioral effects of dietary soy phytoestrogens | Q34522667 | ||
| Botanical and dietary supplements for menopausal symptoms: what works, what does not. | Q35574718 | ||
| The chemical and biologic profile of a red clover (Trifolium pratense L.) phase II clinical extract. | Q35607474 | ||
| Chemical and biological characterization and clinical evaluation of botanical dietary supplements: a phase I red clover extract as a model. | Q35794211 | ||
| A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use. | Q36197949 | ||
| The University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research for Women's Health: from plant to clinical use. | Q36820989 | ||
| Black cohosh (Actaea racemosa, Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human mu opiate receptor | Q36900049 | ||
| Objective hot flashes are negatively related to verbal memory performance in midlife women. | Q37375049 | ||
| Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer | Q39340963 | ||
| Effects of combination estrogen plus progestin hormone treatment on cognition and affect | Q40344974 | ||
| Feasibility and psychometrics of an ambulatory hot flash monitoring device. | Q40797549 | ||
| "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri | Q42555755 | ||
| Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients | Q43576871 | ||
| Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms | Q43614524 | ||
| Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study | Q44234530 | ||
| Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study | Q44469129 | ||
| Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones | Q44535605 | ||
| Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen | Q44591313 | ||
| Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial | Q44967448 | ||
| The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women | Q44982970 | ||
| Memory Functioning Questionnaire: concurrent validity with memory performance and self-reported memory failures | Q46337102 | ||
| The effect of African-American acculturation on neuropsychological test performance in normal and HIV-positive individuals. The HIV Neurobehavioral Research Center (HNRC) Group. | Q46897551 | ||
| Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial | Q46983558 | ||
| Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats | Q48196637 | ||
| Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function | Q48606229 | ||
| Dietary soy phytoestrogens produce anxiolytic effects in the elevated plus-maze | Q48798615 | ||
| Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. | Q50942070 | ||
| Soy phytoestrogens improve radial arm maze performance in ovariectomized retired breeder rats and do not attenuate benefits of 17beta-estradiol treatment. | Q52025617 | ||
| Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. | Q52127221 | ||
| Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory | Q52243867 | ||
| Pituitary hormones during the menopausal hot flash | Q54464995 | ||
| A longitudinal study of cognition change during early menopausal transition in a rural community | Q57665810 | ||
| Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women | Q59647303 | ||
| Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient | Q68831507 | ||
| Laboratory and ambulatory monitoring of menopausal hot flashes | Q69433190 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1167-1177 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Menopause | Q6817295 |
| P1476 | title | Effects of botanicals and combined hormone therapy on cognition in postmenopausal women | |
| P478 | volume | 16 |
| Q38242928 | An Evidence-Based Systematic Review of Black cohosh (Cimicifuga racemosa, Actaea racemosa) by the Natural Standard Research Collaboration |
| Q30634935 | Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies |
| Q37080514 | Discussion of a well-designed clinical trial which did not demonstrate effectiveness: UIC center for botanical dietary supplements research study of black cohosh and red clover |
| Q49841666 | Does phytoestrogen supplementation improve cognition in humans? A systematic review |
| Q37788769 | Effectiveness of phytoestrogens in climacteric medicine |
| Q38194161 | Effects of herbal preparations on symptom clusters during the menopausal transition. |
| Q26773565 | Effects of red clover on hot flash and circulating hormone concentrations in menopausal women: a systematic review and meta-analysis |
| Q90029807 | Effects of soy isoflavones on cognitive function: a systematic review and meta-analysis of randomized controlled trials |
| Q33946509 | Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women |
| Q36901959 | Factors influencing the cognitive and neural effects of hormone treatment during aging in a rodent model |
| Q36887336 | Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on. |
| Q34516562 | Identifying botanical mechanisms of action |
| Q37919098 | Menopausal hot flushes and night sweats: where are we now? |
| Q37146774 | Objective cognitive performance is related to subjective memory complaints in midlife women with moderate to severe vasomotor symptoms |
| Q58781163 | Overview of the Effect of Herbal Medicines and Isoflavones on the Treatment of Cognitive Function |
| Q38700757 | Safety and benefit considerations for menopausal hormone therapy |
| Q39221449 | The menopausal hot flush: a review |
Search more.